Showing results (271-280 of 449) with videos related to
Sort By:
Pageof 45
Nature Cell Biology|January 30, 2019
AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functionsJianping Guo, Xiangpeng Dai, Benoit Laurent, et al.Cell|July 9, 2013
MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodelingSu Jung Song, Laura Poliseno, Min Sup Song, et al.Nature Medicine|January 9, 2018
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanismsMarco Bezzi, Nina Seitzer, Tomoki Ishikawa, et al.Nature Genetics|August 22, 2020
Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostateBrett S Carver, Jennifer Tran, Anuradha Gopalan, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 30, 2009
Development of promyelocytic zinc finger and ThPOK-expressing innate gamma delta T cells is controlled by strength of TCR signaling and Id3Eric S Alonzo, Rachel A Gottschalk, Joy Das, et al.The Journal of Pathology|March 12, 2014
Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathwayFederica Fusella, Roberta Ferretti, Daniele Recupero, et al.Nature Genetics|April 28, 2009
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostateBrett S Carver, Jennifer Tran, Anuradha Gopalan, et al.Proceedings of the National Academy of Sciences of the United States of America|June 28, 2013
Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancersMichael Pourdehnad, Morgan L Truitt, Imran N Siddiqi, et al.Molecular Cell|June 17, 2022
The promises and pitfalls of specialized ribosomesMaria Barna, Katrin Karbstein, David Tollervey, et al.Science (New York, N.Y.)|May 13, 2006
Impaired control of IRES-mediated translation in X-linked dyskeratosis congenitaAndrew Yoon, Guang Peng, Yves Brandenburger, et al.Pageof 45